rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
1999-12-17
|
pubmed:abstractText |
Amifostine is a new cancer-supporting agent to protect normal tissue in patients receiving radio-chemotherapy. The main question of our study is whether the application of amifostine can be limited on the duration of chemotherapy in patients with advanced head and neck tumors undergoing radio-chemotherapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0179-7158
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
175 Suppl 4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
23-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10584136-Adolescent,
pubmed-meshheading:10584136-Adult,
pubmed-meshheading:10584136-Aged,
pubmed-meshheading:10584136-Amifostine,
pubmed-meshheading:10584136-Antineoplastic Agents,
pubmed-meshheading:10584136-Carboplatin,
pubmed-meshheading:10584136-Carcinoma, Squamous Cell,
pubmed-meshheading:10584136-Combined Modality Therapy,
pubmed-meshheading:10584136-Head and Neck Neoplasms,
pubmed-meshheading:10584136-Humans,
pubmed-meshheading:10584136-Leukocyte Count,
pubmed-meshheading:10584136-Middle Aged,
pubmed-meshheading:10584136-Platelet Count,
pubmed-meshheading:10584136-Prognosis,
pubmed-meshheading:10584136-Radiation-Protective Agents,
pubmed-meshheading:10584136-Radiodermatitis,
pubmed-meshheading:10584136-Radiotherapy,
pubmed-meshheading:10584136-Radiotherapy Dosage,
pubmed-meshheading:10584136-Salivary Glands,
pubmed-meshheading:10584136-Skin Temperature,
pubmed-meshheading:10584136-Time Factors
|
pubmed:year |
1999
|
pubmed:articleTitle |
Supportive use of amifostine in patients with head and neck tumors undergoing radio-chemotherapy. Is it possible to limit the duration of the application of amifostine?
|
pubmed:affiliation |
Klinik und Poliklinik für Strahlentherapie, Universität Rostock, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|